> Medicinal products that may increase plasma POTASSIUM or induce hyperkalaemia 
> Concomitant use of SIBNAYAL with medicinal  products that may increase POTASSIUM levels or induce hyperkalaemia  (e.g.  ACE inhibitors, POTASSIUM -sparing DIURETICS, POTASSIUM supplements, salt substitutes containing POTASSIUM, CICLOSPORIN or other medicinal products such as HEPARIN sodium or nonsteroidal anti -inflammatory medicinal products ) necessitates monitoring of pota ssium plasma levels  (see section 4.4) . 
> RTA  have alkaline urine due to their proton secretion defect. This may impact the excretion of the medicinal product into the urine (such as an increase of the elimination of salicylates, TETRACYCLINES, and barbiturates and a decrease in the elimination of QUINIDINE) or reduce the effectiveness of methenamine. As SIBNAYAL may further increase urine p
